Pharma-Bio Serv (OTCMKTS:PBSV) Posts Earnings Results, Beats Estimates By $0.35 EPS

Posted by Wayne Rhoads on Mar 19th, 2025

Pharma-Bio Serv (OTCMKTS:PBSV – Get Free Report) released its quarterly earnings data on Monday. The company reported $0.37 earnings per share for the quarter, topping analysts’ consensus estimates of $0.02 by $0.35, reports. Pharma-Bio Serv had a negative return on equity of 5.61% and a negative net margin of 8.18%. The firm had revenue of $2.47 million during the quarter, compared to analyst estimates of $2.70 million.

Pharma-Bio Serv Trading Down 21.8 %

Shares of Pharma-Bio Serv stock opened at $0.43 on Wednesday. The stock has a 50 day moving average of $0.55 and a 200 day moving average of $0.57. Pharma-Bio Serv has a 12 month low of $0.31 and a 12 month high of $0.90. The firm has a market cap of $9.86 million, a PE ratio of -14.33 and a beta of 0.53.

Pharma-Bio Serv Announces Dividend

The company also recently declared a dividend, which will be paid on Thursday, March 20th. Investors of record on Friday, February 28th will be paid a dividend of $0.075 per share. The ex-dividend date of this dividend is Friday, February 28th. Pharma-Bio Serv’s payout ratio is presently -250.00%.

Pharma-Bio Serv Company Profile

(Get Free Report)

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.